Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
CA 2494485 A1 · Owner: Kiener, Peter · Inventors: Fouchier, Ronaldus A. M.; Osterhaus, Albertus D. M. E.; Young, James F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods for broad spectrum prevention and treatment of viral respiratory infections. In particular the present , invention relates to methods for preventing treating or ameliorating symptoms , associated with respiratory syncytial virus (RSV) parainfluenza virus (PIV), and/or human metapneumovirus (hMPV) infection the methods comprising , administering to a subject an effective amount of one or more anti-RSV-antigen antibodies or antigen-binding fragments thereof one or more anti-hMPV-antigen , antibodies or antigen-binding fragments thereof and/or one or more anti-PIV-, antigen antibodies or antigen-binding fragments thereof. In certain embodiments, a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 25, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 25, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 25, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.